enVVeno Medical Corporation (NASDAQ:NVNO) Director Robert Gray Buys 3,500 Shares

enVVeno Medical Corporation (NASDAQ:NVNO) Director Robert Gray acquired 3,500 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The shares were acquired at an average cost of $2.94 per share, for a total transaction of $10,290.00. Following the purchase, the director now directly owns 11,155 shares in the company, valued at $32,795.70. This trade represents a 45.72 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

enVVeno Medical Price Performance

Shares of enVVeno Medical stock traded up $0.05 during trading hours on Thursday, hitting $3.07. The company’s stock had a trading volume of 34,365 shares, compared to its average volume of 115,468. enVVeno Medical Corporation has a 12 month low of $2.45 and a 12 month high of $6.97. The company has a market capitalization of $53.85 million, a PE ratio of -2.38 and a beta of 1.22. The stock has a 50 day moving average of $3.17 and a 200 day moving average of $4.26.

enVVeno Medical (NASDAQ:NVNO) last announced its quarterly earnings results on Thursday, October 31st. The company reported ($0.35) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.02). Equities analysts expect that enVVeno Medical Corporation will post -1.3 EPS for the current year.

Hedge Funds Weigh In On enVVeno Medical

A number of large investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC lifted its holdings in shares of enVVeno Medical by 7.8% in the third quarter. Geode Capital Management LLC now owns 150,676 shares of the company’s stock valued at $506,000 after purchasing an additional 10,902 shares in the last quarter. Corsair Capital Management L.P. acquired a new stake in enVVeno Medical in the 3rd quarter valued at approximately $390,000. Westside Investment Management Inc. lifted its stake in enVVeno Medical by 128.0% in the 3rd quarter. Westside Investment Management Inc. now owns 88,375 shares of the company’s stock valued at $297,000 after acquiring an additional 49,613 shares in the last quarter. Maven Securities LTD acquired a new position in enVVeno Medical during the 3rd quarter worth approximately $295,000. Finally, Hohimer Wealth Management LLC bought a new position in shares of enVVeno Medical during the 3rd quarter worth approximately $286,000. Institutional investors own 34.71% of the company’s stock.

About enVVeno Medical

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).